Completed PHASE4 INTERVENTIONAL 2-arm NCT01049321

The Effect of DASH Diet on the Cardiometabolic Risks and Hepatic Function Among Type 2 Diabetic Patients

Sponsor: Isfahan University of Medical Sciences

Interventions DASH diet a usual diabetic diet

Updated 5 times since 2017 Last updated: Jan 13, 2010 Started: Dec 31, 2008 Primary completion: Jun 30, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01049321, this PHASE4 trial focuses on Type 2 Diabetic Patients and remains completed. Sponsored by Isfahan University of Medical Sciences, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Isfahan University of Medical Sciences
Shahid Motahari Hospital of Fooladshahr, Isfahan Steel Company, Isfahan

Data source: Isfahan University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Isfahan, Iran